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Abstract
Background: Hospital-acquired infections (HAIs) are a well-known cause of morbidity and mortality in hospitalized
patients. This study aimed at investigating the survival rate in patients with ICU-acquired infections (ICU-AIs) and its
related factors in Iran’s hospitals.
Methods: Data were obtained from the Iranian Nosocomial Infections Surveillance (INIS), which registers all
necessary information on the main types of infection from different units of each included hospital. One thousand
one hundred thirty-four duplicate cases were removed from the analysis using the variables of name, father’s name,
age, hospital code, infection code, and bedridden date. From 2016 to 2019, 32,998 patients diagnosed with ICU-AI
from about 547 hospitals. All patients were followed up to February 29, 2020.
Results: The median age of patients with ICU-AIs was 61 (IQR = 46) years. 45.5, 20.69, 17.63, 12.08, and 4.09% of
infections were observed in general, surgical, internal, neonatal and pediatric ICUs, respectively. Acinetobacter
(16.52%), E.coli (12.01%), and Klebsiella (9.93%) were the major types of microorganisms. From total, 40.76% of
infected patients (13,449 patients) died. The 1, 3, 6-months and overall survival rate was 70, 25.72, 8.21 1.48% in ICU-
AI patients, respectively. The overall survival rate was 5.12, 1.34, 0.0, 51.65, and 31.08% for surgical, general, internal,
neonatal and pediatric ICU, respectively. Hazard ratio shows a significant relationship between age, hospitalization-
infection length, infection type, and microorganism and risk of death in patients with ICU-AI.
Conclusions: Based on the results, it seems that the nosocomial infections surveillance system should be more
intelligent. This intelligence should act differently based on related factors such as the age of patients,
hospitalization-infection length, infection type, microorganism and type of ward. In other words, this system should
be able to dynamically provide the necessary and timely warnings based on the factors affecting the survival rate
of infection due to the identification, intervention and measures to prevent the spread of HAIs based on a risk
severity system.
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Introduction
Hospital-acquired infections (HAIs) are infections that
are not present in patients at the time of hospital ad-
mission and also are not in the incubation period.
These infections occur after hospitalization, especially
within 48–72 h after hospital admission and up to 6
weeks later [1].
These infections are a well-known cause of morbidity
and mortality in hospitalized patients which in fact com-
plicate hospitalization and treatment processes [2, 3].
These infections include the ventilator-associated
events/ respiratory infections/pneumonia (VAE/VAP),
central line-associated bloodstream infections/ septi-
cemia (CLABSI), catheter-related urinary tract infection
(CAUTI), surgical site infections (SSI), and clostrid-
ium difficile infections (CDI) [4]. In addition, the risk
factors for these infections include the immunosuppres-
sion, older age, longer length of stay in hospital, multiple
underlying comorbidities, frequent visits to healthcare
facilities, mechanical ventilatory support, recent invasive
procedures, indwelling devices, and stay in an intensive
care unit (ICU) [5].
The risk of these infections is higher in the intensive
care unit, so that in a study of 231,459 patients admitted
to the intensive care unit of 947 hospitals in Germany
(2015), the point prevalence of ICU-acquired infections
(ICU-AIs) was 19.5% [6]. While in study by Magill et al.
(2014) on 11,282 patients from 183 U.S. acute care hos-
pitals, the overall point prevalence of these infections
was only 4% [7].
Various studies have shown that the incidence of
hospital-acquired infections in the intensive care unit is
5 to 10 times higher than in other hospital wards [8].
Some other studies have also shown that 50% of patients
admitted to the intensive care unit affected from this in-
fections [9, 10]. Accordingly, these infections are in fact,
serious problem which complicate the patients in the in-
tensive care unit [11]. Because the high prevalence of
these infections in the intensive care unit, it leads to in-
crease in morbidity and mortality of hospitalized pa-
tients. It also increase the economic burden due to
higher prescription of antibiotics and longer hospital
stay in hospitals [8, 11].
Although the prevalence of HAIs and its related fac-
tors have been widely studied, no special study has been
conducted in Iran regarding their survival rate of such
patients, especially those admitted in ICUs. Therefore,
this study aimed at investigating the survival rate in pa-
tients with ICU-acquired infections and its related fac-
tors in Iran’s hospitals.
Methods
In this retrospective cohort study, data were obtained
from the Iranian Nosocomial Infections Surveillance
(INIS), which uses the standard definitions provided
by the national nosocomial infections surveillance sys-
tem (NNIS). The NNIS registers four main types of
infection, including the following: catheter-associated
urinary tract infections (CAUTI), ventilator-associated
events (VAE), surgical site infections (SSI), central
line-associated bloodstream infections (CLABSI) and
other infections (bone and joint, central nervous sys-
tem, chorionic villus sampling, eye, ear, nose, throat
and mouth, gastrointestinal system, reproductive tract
infection, and skin and soft tissue infections). It also
records different types of information in different
units of each hospital [12]. For the purpose of this
study, following variables were included: age, gender,
hospitalization-infection length, duration of
hospitalization, type of ward, type of infection, device
use (different types of catheters include the urinary
catheter, artery catheter, umbilical catheter, peripheral
venous catheter, temporary central venous and per-
manent central venous catheter and also ventilator),
type of microorganism, type of hospital, and death
status. The primary outcome for this study was all
cause death among patients with HAIs admitted to
the ICU. Follow-up time was considered for one year,
whether discharged or death.
Statistical analysis
The median (Interquartile Range = IQR) and count (per-
centage) were used to describe quantitative and qualita-
tive variables, respectively. The Chi-square test
calculated the frequency of different variables among the
two groups (alive and dead). The Kaplan Meier was used
to compare survival rates between different groups. In
addition, we used the Cox proportional hazard regres-
sion model to estimate the crude and adjusted hazard
ratio (HR) for the risk of death among patients with
ICU-acquired infection. To identify the factors related to
survival in patients with ICU-acquired infections, all the
variables with a P-value less than 0.2 or variables whose
most levels are less than 0.2 at the univariable model
were included in the multivariable analysis. Data were
analyzed by the Stata (version 14.0; Stata Corp, Texas,
USA) software. For all statistical tests P < 0.05 was con-
sidered statistically significant.
This study was approved by the ethical committee of
National Institute for Medical Research Development
(IR.NIMAD.REC.1399.074).
Results
One thousand one hundred thirty-four duplicate cases
were removed from the analysis by matching name,
father’s name, age, hospital code, infection code, and
bedridden date. Finally, the 32,998 patients diagnosed
with ICU-AI from about 547 hospitals between 2016
Etemad et al. BMC Public Health          (2021) 21:787 Page 2 of 9
Table 1 Factors associated with the all-cause mortality among ICU-acquired infections patients
Variable Alive (19,549) Dead (13,449) Total (32,998) P-value*
N (%) N (%) N
Gender Male 11,782 (61.36) 7420 (38.64) 19,202 < 0.001
Female 7727 (56.2) 6021 (43.8) 13,748
Hospitalization-infection length ≤8 days 11,241 (65.09) 6030 (34.91) 17,271 < 0.001
> 8 days 8308 (52.83) 7419 (47.17) 15,727
Ward type Surgical ICU 4087 (59.86) 2741 (40.14) 6828 < 0.001
General ICU 8228 (54.8) 6786 (45.2) 15,014
Internal ICU 2743 (47.15) 3075 (52.85) 5818
Pediatric ICU 1030 (76.24) 321 (23.76) 1361
Neonatal ICU 3461 (86.81) 526 (13.19) 3987
Infection type BSI 2470 (58.45) 1756 (41.55) 4226 < 0.001
PENU & LRTI 3404 (71.66) 1346 (28.34) 4750
SSI 1333 (71.13) 541 (28.87) 1874
UTI 4008 (61.66) 2492 (38.34) 6500
VAE 6421 (48.97) 6690 (51.03) 13,111
Other 1913 (75. 4) 624 (24. 6) 2537
Device use Yes 11,023 (52.76) 9870 (47.24) 20,893 < 0.001
No 8526 (70.43) 3579 (29.57) 12,105
Device type Catheters 3633 (56.46) 2802 (43.54) 6435 < 0.001
Ventilators 6820 (50.13) 6784 (49.87) 13,604
Other 570 (66.74) 284 (33.26) 854
Without device 8526 (70.43) 3579 (29.57) 12,105
Microorganism Staphylococcus epidermidis 885 (73.26) 323 (26.74) 1208 < 0.001
Staphylococcus aureus 995 (62.66) 593 (37.34) 1588
Coagulase negative staphylococci 548 (66.26) 279 (33.74) 827
Acinetobacter 2617 (48.01) 2834 (51.99) 5451
Escherichia coli 2373 (59.89) 1589 (40.11) 3962
Enterobacter 901 (63.18) 525 (36.82) 1426
Enterococcus 435 (59.92) 291 (40.08) 726
Pseudomonas aeruginosa 1474 (58.28) 1055 (41.72) 2529
Citrobacter 328 (58.89) 229 (41.11) 557
Candida 467 (45.43) 561 (54.75) 1028
Candida albicans 284 (55.15) 231 (44.85) 515
Klebsiella 1875 (57.23) 1401 (42.77) 3276
Klebsiella pneumoniae 921 (48.78) 967 (51.22) 1888
Other 1804 (62.6) 1078 (37.4) 2882
Unknown 3642 (70.93) 1493 (29.07) 5135
Hospital type Government 16,121 (59.45) 10,998 (40.55) 27,119 < 0.001
Semi-government 581 (43.78) 746 (56.22) 1327
Private 2045 (63.14) 1194 (36.86) 3239
Other 516 (53.86) 442 (46.99) 958
*Based on Chi-square test
BSI Blood Stream Infections, PENU & LRI Pneumonia Events & Lower Respiratory Tract Infection, SSI Surgical Site Infection, UTI Urinary Tract Infection, VAE Ventilator
Associated Events.
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and 2019 were eligible for analysis. The median age
of 32,998 patients with ICU-acquired infections was
61 (IQR = 46) years. 58.28% (19,202) of patients were
males. The median of hospitalization-infection length
and hospitalization duration were 8 (IQR = 16) and 23
(IQR = 29) days, respectively. 45.5, 20.69, 17.63, 12.08,
and 4.09% of infections were observed in general, sur-
gical, internal, neonatal and pediatric ICUs, respect-
ively. For 63.32% of patients, the device (catheter and
ventilator) was used. The most common ICU-AIs
were VAE (13,111 patients; 39.73%). The major type
of microorganisms were Acinetobacter (16.52%), E.coli
(12.01%), and Klebsiella (9.93%). From total, 40.76%
of infected patients (13,449 patients) died. Variables
associated with death of such patients were investi-
gated and have been shown in Table 1.
The survival rate
The 1, 3, 6-months and overall survival rate was 70,
25.72, 8.21 1.48% in ICU-acquired infections patients, re-
spectively (Fig. 1). The 1, 3, 6-months and overall sur-
vival rates in males were higher than females (Fig. 2).
The overall survival rate was 5.12, 1.34, 0.0, 51.65, and
31.08% for surgical, general, internal, neonatal and
pediatric ICU, respectively. Also, the 6-months and the
overall survival rate among neonates (51.65%) was sig-
nificantly higher compared to other age groups (Fig. 3).























Fig. 2 The overall survival among ICU-acquired infections patients by gender
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The risk of death in patients with ICU-acquired infection
The association between different variables and risk of
death were investigated and have been presented in
Appendix 1, Table 2.
General ICU
Based on multivariable Cox regression, with increasing
one year of age, the risk of death in ICU-AI patients in-
creases by 1% (HR = 1.01; 95% CI: 1.009–1.01). The risk
of death was 6% higher in women than men (HR = 1.06;
95% CI: 1.01–1.011). The hospitalization-infection
length > 8 days was associated with a 64% decrease in the
number of deaths in ICU-acquired infections (HR = 0.36;
95% CI: 0.34–0.38). The use of a device (catheter and
ventilator) was also associated with a 16% increase in
death risk (HR = 1.16; 95% CI: 1.1–1.23). Considering
the types of microorganisms, the largest increase in
death risk was related to the Acinetobacter (HR = 1.25;
95% CI: 1.06–1.48) (Table 2).
Internal ICU
The risk of death in ICU-AI patients increases by
0.9% (HR = 1.009; 95% CI: 1.007–1.01) with increasing
1 year of age. The hospitalization-infection length > 8
days was associated with a 63% decrease in the num-
ber of death in ICU-acquired infections patients
(HR = 0.37; 95% CI: 0.34–0.4). In addition, the risk of
death was 34% (HR = 1.34; 95% CI: 1.09–1.64) and
50% (HR = 1.5; 95% CI: 1.16–1.92) higher in govern-
ment and semi-government hospitals compare to
private hospitals. Considering the types of microor-
ganisms, the largest increase in the risk of death was
related to the Candida (HR = 2.76; 95% CI: 1.95–3.9),
Enterococcus (HR = 2.09; 95% CI: 1.44–3.03), and Aci-
netobacter (HR = 1.97; 95% CI: 1.45–2.68) (Table 2).
Surgical ICU
With increasing 1 year of age, the risk of death in ICU-
AI patients increases by 1.7% (HR = 1.017; 95% CI:
1.015–1.019). The risk of death was 13% higher in
women than men (HR = 1.13; 95% CI: 1.05–1.22). The
hospitalization-infection length > 8 days was associated
with a 58% decrease in the number of deaths in ICU-
acquired infections (HR = 0.42; 95% CI: 0.39–0.46). In
addition, based on type of infection, BSI, VAE and other
type of infections increase the risk of death by 50%
(HR = 1.5; 95% CI: 1.26–1.78), 33% (HR = 1.33; 95% CI:
1.14–1.54), and 90% (HR = 1.9; 95% CI: 1.54–2.34), re-
spectively. Considering the types of microorganisms, the
largest increase in the risk of death was related to the
Candida (HR = 1.54; 95% CI: 1.15–2.06), Coagulase nega-
tive staphylococci (HR = 1.54; 95% CI: 1.08–2.19), and
Escherichia coli (HR = 1.41; 95% CI: 1.1–1.82) (Table 2).
Pediatric ICU
The risk of death in PICU was only associated with
hospitalization-infection length (HR = 0.45; 95% CI:
0.35–0.57) (Table 2).
Neonatal ICU
The hospitalization-infection length > 8 days was associ-
ated with a 61% decrease in the number of death in
ICU-acquired infections patients (HR = 0.39; 95% CI:
0.32–0.48). Based on the type of infection, BSI and VAE
increase death risk (HR = 2.35; 95% CI: 1.3–4.26) and
(HR = 2.05; 95% CI: 1.09–3.87). In addition, the use of a
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Fig. 3 The overall survival among ICU-acquired infections patients by ward type
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Table 2 Multiple Cox regression analysis of survival of ICU-acquired infection patients by ward type
Variable Adjusted HR (95% CI)
General ICU Internal ICU Surgical ICU Pediatric ICU Neonatal ICU







Gender Male 1 1 1 1 1
Female 1.06* (1.01–
1.11)
1.06 (0.99–1.14) 1.13* (1.05–1.22) – –
Hospitalization-infection
length
≤8 days 1 1 1 1 1
> 8 days 0.36* (0.34–
0.38)




Infection type BSI – 1.5* (1.15–1.95) 1.5* (1.26–1.78) – 2.35* (1.3–
4.26)
PENU & LRI – 1.35* (1.02–1.77) 0.96 (0.79–1.17) – 1.26 (0.69–
2.31)
SSI 1 1 1 1 1
UTI – 1.23 (0.95–1.59) 1.04 (0.87–1.24) – 0.56 (0.27–
1.18)
VAE – 1.51* (1.19–1.93) 1.33* (1.14–1.54) – 2.05* (1.09–
3.87)
Other – 1.43* (1.07–1.92) 1.9* (1.54–2.34) – 0.62 (0.33–
1.17)
Device use No 1 1 1 1 1




Microorganism Staphylococcus epidermidis 1 1 1 1 1
Staphylococcus aureus 0.98 (0.81–
1.19)




1.1 (0.88–1.38) 1.54* (1.08–2.19) 1.5* (1.01–2.21) – 0.76 (0.4–1.46)
Acinetobacter 1.25* (1.06–
1.48)
1.31* (1.03–1.66) 1.97* (1.45–2.68) – 2.91* (1.86–
4.54)








1.26 (0.9–1.76) 2.09* (1.44–3.03) – 1.74 (0.84–
3.61)








1.54* (1.15–2.06) 2.76* (1.95–3.9) – 4.9* (2.22–
10.81)
Candida albicans 1.26 (0.99–
1.61)




1.4* (1.09–1.8) 1.62* (1.17–2.24) – 2.52* (1.56–
4.04)
Klebsiella pneumoniae 0.96 (0.8–1.15) 1.29 (0.98–1.69) 1.77* (1.29–2.45) – 2.3* (1.3–4.08)
Other 0.99 (0.83–
1.19)




1.4* (1.08–1.81) 1.87* (1.17–2.22) – 1.86* (1.19–
2.9)
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a 26% increase in the risk of death (HR = 1.26; 95% CI:
1.02–1.56). Considering the types of microorganisms,
the largest increase in the risk of death was related to
the Candida (HR = 4.9; 95% CI: 2.22–10.81), Candida
Albicans (HR = 2.95; 95% CI: 1.33–6.5), Enterobacter
(HR = 2.92; 95% CI: 1.77–4.81), and Acinetobacter (HR =
2.91; 95% CI: 1.86–4.54) (Table 2).
Discussion
Our study showed that the survival rate in HAIs patients
decreases over time. The reason for such decrease is
multifactorial and is at least partly due to the possible
change of pattern of infection over time, in which more
than one organism may contribute to occurrence of
HAIs. This in turn might be due to improper treatment
of HAIs, multi-drug resistance, low quality of care for
patients after their discharge from hospital [13–16].
According to the results of this study, the risk of death
in women with HAIs admitted to the intensive care unit
in general and surgical ICUs was higher than men. This
result needs further investigation because the results
from elsewhere is not consistent [8, 17]. However, the
results of our study seem to be more reliable considering
that its sample size is larger than most of other reports.
Our results, are in fact, based on a national registration
system.
In terms of type of ICU, the survival rate was higher in
neonatal and pediatric ICUs and it may be because of
the effect of age which is the main variable differed
among such patients. Our finding is consistent with re-
ports from elsewhere [18–21].
Studies have shown that increasing the length of
hospitalization in the ICUs, increases the risk of HAIs.
However, they do not necessarily increase the risk of
death [22–25]. The main finding of this study was that
hospitalization in the ICU for more than 8 days increases
the survival in patients with nosocomial infections. The
reason for such improvement in survival might be due
to better care given to such patients which in turn lead
to have a better condition for them [13]. Of course, it’s
worthwhile to mention that the overall survival rate de-
creases with the prolong hospitalization in ICUs which
is different based on type of microorganism.
Based on our study, blood stream infections (BSI)
and infections associated with ventilator and catheter
events lead to an increased risk of death and de-
creased survival rate in patients with HAIs admitted
to the ICU. In our study, the most common microor-
ganisms that increased the risk of death and de-
creased survival rate were: Candida Albicans, Candida,
Acinetobacter, Enterococcus and Enterobacter. These
findings are consistent with the results of other re-
ports [13, 26–29]. Therefore, it is of high importance
to pay special attention to these microorganisms,
while trying to prevent their occurrence, considering
appropriate and adequate treatment for each of these
cases are essential.
This study was the first comprehensive and national
study conducted on the survival rate in patients with ICU-
acquired infections and its related factors in Iran’s hospi-
tals using a nationwide registered data. Although, its
coverage is about 83.5% and therefore it is not
generalizable to not cover hospitals, but a random selec-
tion of all included hospitals almost represent the national
situation of ICU-AIs and provide a national view.
On the other hand, the surveillance data are often lim-
ited in terms of recorded variables. Different scoring sys-
tems based on clinical and laboratory findings that
predict the mortality in patients with critical situations
such as the acute physiology and chronic health evalu-
ation (APACHE) score, sequential organ failure assess-
ment (SOFA), mortality in emergency department sepsis
(MEDS), and other similar scoring systems are not cov-
ered in the INIS dataset. Therefore, we were not able to
assess the effect of such variables on mortality at ICU
admission.
Conclusions
Despite the above mentioned limitations of the
nosocomial infection surveillance system, the results of
our report, provided a general picture for the survival
rate and its related risk factors among ICU-AIs. It seems
that the nosocomial infections surveillance system
should be more intelligent. This intelligence should act
differently based on related factors such as the age of pa-
tients, hospitalization-infection length, infection type,
Table 2 Multiple Cox regression analysis of survival of ICU-acquired infection patients by ward type (Continued)
Variable Adjusted HR (95% CI)
General ICU Internal ICU Surgical ICU Pediatric ICU Neonatal ICU
Hospital type Government – 1.34* (1.09–1.64) – – –
Semi-government – 1.5* (1.16–1.92) – – –
Private 1 1 1 1 1
Other – 1.07 (0.84–1.37) – – –
*P < 0.05
HR Hazard Ratio, CI Confidence Interval, BSI Blood Stream Infections, PENU & LRI Pneumonia Events & Lower Respiratory Tract Infection, SSI Surgical Site Infection,
UTI Urinary Tract Infection, VAE Ventilator Associated Events.
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microorganism and type of ward. In other words, this
system should be able to dynamically provide the neces-
sary and timely warnings based on the factors affecting
the survival rate of infection due to the identification,
intervention and measures to prevent the spread of HAIs
based on a risk severity system.
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